Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27-30 November 2023 -... Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27-30 November 2023

At its monthly meeting, EMA's
committee recommended measures for medicines containing #pseudoephedrine & agreed to request further evidence in the #GLP1receptor agonists’ review.

www.ema.europa.eu/en/news/meet...